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Abstract
Aim: To study the age when symptoms of adverse reactions to milk occur, in premature and term
children, the debut of various symptoms, immunoglobulin E (IgE)- and non-IgE-mediated reactions
and the frequency of tolerance at 1 year.
Methods: Six hundred and eight children, 193 premature and 416 term infants, were followed.
Symptomatic children were invited to a clinical examination. The criteria for the diagnosis were:
histories of suspected cow’s milk allergy (CMA) and proven IgE-mediated reactions to cow’s milk or
positive elimination/challenge tests.
Results: Twenty-seven out of 555 (4.9%) were diagnosed with adverse reactions to cow’s milk. All
had symptoms before 6 months of age. The main symptoms were: pain behaviour (13),
gastrointestinal symptoms (7), respiratory symptoms, (6) and atopic dermatitis (1). One child had
proven IgE to cow’s milk. Premature and term infants displayed the same symptoms and age of
debut. Thirteen children were tolerant to cow’s milk at 1 year.
Conclusion: Adverse reactions to milk start early in life, with pain behaviour, gastrointestinal, and respiratory
symptoms being the most common, and rarely atopic dermatitis. Non-IgE-mediated reactions were the most
frequent. Symptoms and age of debut were the same in premature and term infants. Half of the children
tolerated cow’s milk at age 1.
INTRODUCTION
Adverse reactions to cow’s milk are frequent in the first year
of life. The symptoms may start during the first weeks of
life and may be cutaneous (50–60%), gastrointestinal (50–
60%) or respiratory (20–30%), often with symptoms in more
than one organ system (1). The reported frequency of cow’s
milk allergy (CMA) in the first year of life is between 2
and 7% (2,3). It is well known that most children outgrow
their adverse reactions to cow’s milk during the first year of
life (4). According to a 2002 review that was based on 229
PUBMED articles, the frequency of tolerance at 1 year was
45–50% and at 2 years of age was 60–75% (1). The diag-
nosis was made on the background of reproducible adverse
reactions to cow’s milk proteins, confirmed by controlled
elimination/challenge tests (1).
Adverse reactions to cow’s milk may be either im-
munoglobulin (IgE) or non-IgE mediated, but there are few
published reports of the relationship between the two. In the
few existing reports, the frequency of IgE-mediated allergies
varied from 26% to 73% of the total adverse reactions to
milk (5,6).
As there are few reports in the literature on adverse re-
actions to milk during the first year of life, we wanted to
study this in infancy. The aim of the present study was to
define the age when the first symptoms of adverse reactions
to milk occur, the occurrence of symptoms in multiple organ
systems, the frequency of tolerance at 1 year of age, as well as
to establish the incidence of IgE-mediated allergy and non-
IgE-mediated adverse reactions. Furthermore, we wanted to
investigate and compare possible differences in occurrence
and symptomatology in premature children (whose immune
system is not fully matured) and term children. Some in-
vestigators have reported fewer allergies among premature
children (7–9).
PATIENTS AND METHODS
Study population
One hundred and ninety-three premature infants, gesta-
tional age (GA) 28 to 35 weeks; birth weight, mean 2224
(1214–2880) g (Table 1), born consecutively at the maternity
clinic of Oestfold Hospital Trust, and the two following chil-
dren born at term, birth weight, mean 3648 (2650–5050)
g, total number 609. At the 1-year follow-up, 555 children
(91%ofthetotalpopulation)participated,166(86%)prema-
ture and 389 (93%) term children. The mothers were asked
to participate during the first 4 days after delivery. Verbal
and written information were given, and a written consent
was collected from those who agreed to participate. All the
families were given the cell phone number of the investi-
gator, and were instructed to call if there was any sign of
illness.
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Table 1 Premature children, GA and birth weight
Patient number GA (months) Birth weight (g)
1 33 2815
2 33 2310
3 35 2220
42 9 1 2 3 2
63 4 2 1 2 0
7 34 2350
8 35 2880
92 8 1 2 4 1
Exclusion criteria
Families not situated in Oestfold county or the southern
part of Akershus county, families unable to communicate in
Norwegian, families not capable of participating for other
obvious reasons and children presenting with other or seri-
ous diseases were excluded.
Questionnaires and interviews
A written questionnaire was recorded at the time of inclu-
sion, and at the 6- and 12-month follow-up. One of the par-
ents was interviewed by phone at 1, 4 and 12 months after
inclusion, and specifically asked about abdominal and res-
piratory symptoms, skin rashes and pain behaviour. They
were also questioned about whether or not they felt their
child was healthy.
Children with symptoms consistent with possible adverse
reactions to milk, as well as children whose parents did not
consider them to be completely healthy, were invited to the
outpatient clinic at the hospital in Fredrikstad within the
following 4 to 5 days. A general clinical examination was
performed, with special focus on skin, lung and abdominal
conditions.
Skin prick test (SPT)
SPT were performed on both lower arms with 1-mm tip
lancet (ALK-Abello, Copenhagen, Denmark) and allergen
extracts from milk, egg, cod, hazel nuts, peanuts, wheat
and soy (ALK-Abello). Histamine chloride 10 mg/mL (ALK-
Abello) was used as a positive control, and NaCl 0.9% as a
negative control. The SPT was read after 13 min. The con-
tours of the wheals were encircled by a pen, with the two
diameters perpendicular to each other, measured in millime-
tre, added and divided by two. The results were presented in
millimetre. SPT equal to or greater than 3 mm was consid-
ered positive.
Faecal blood
The diapers of children were analyzed with hemofec A and
B for the detection of blood in their stool. The test was per-
formed on at least two different locations of the diaper, and
a change in colour within 3 sec was considered positive.
Total and specific IgE
Blood was drawn to determine total and specific IgE against
foodandinhalantallergens(Alastat,DPC,LosAngeles,CA).
The analyses were performed at the department of clinical
chemistry, Oestfold Hospital Trust.
Elimination/challenge test
Immediately after their first examination, the infants were
fed a diet totally free from cow’s milk proteins for 14 days.
As a milk substitute, an extensively hydrolyzed formula was
introduced. For those who were not exclusively fed with
milk, porridge was made with the same formula. In breastfed
infants, the mother was given detailed dietary instructions
on how to follow an elimination diet free from cow’s milk
proteins.
A symptom score diary card was filled out daily by one of
the parents, with special focus on respiratory symptoms like
apnoeorcoughing,painbehaviourrecordedascryinghours,
gastrointestinalsymptomslikevomitingordiarrhoea,aswell
as observed blood in the stool. Furthermore, the appearance
of skin rashes and itching were noted in detail.
The challenge was performed by introducing cow’s milk
proteins either by formula to the infant or through the
mother’s milk. The reappearance of symptoms, whether in
hours or days, was noted. The challenge was considered
positive when symptoms reappeared with reintroduction of
cow’s milk proteins. The change in symptoms had to be re-
producible, and thus the elimination/challenge test was re-
peated at least once.
Scoring atopic dermatitis (SCORAD) index
The children with atopic dermatitis were evaluated accord-
ing to SCORAD index (10).
Diagnosis
The diagnosis of CMA was based on the following criteria:
(1) A history of suspected CMA, a positive SPT and an
elevated specific IgE to cow’s milk.
(2) A history of suspected CMA, a negative SPT, a negative
specific IgE to cow’s milk and an elimination/challenge
test performed twice; both tests had to be positive.
At 1 year of age, all the children had an open challenge
with cow’s milk proteins. The children were fed their usual
porridge made with cow’s milk. If no adverse reactions ap-
peared within a week, they were introduced to cow’s milk
to drink.
Statistical analysis
Categorical response variables were compared between
groups using Pearson’s Chi-square test. Changes within one
group were assessed using Mc Nemars test. An unpaired
t-test was used to compare continuous background vari-
ables. All p-values equal to or below 0.05 were considered
significant. Statistical analyses were performed with SPSS
software, version 14.0 (SPSS, Inc., Chicago, IL).
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Figure 1 Presenting symptoms of adverse reactions to cow’s milk in infants.
RESULTS
Of the 555 children in 1-year follow-up, 87 reported symp-
toms and were examined at the hospital. According to the
diagnostic criteria, 27 of 555 children (4.9%) were diagnosed
with adverse reactions to milk. Twenty-six children were
diagnosedbyelimination/challengetests;allbutoneofthese
was exclusively fed with milk. Seventeen of the 27 children
presented with symptoms within the first 4 weeks of life. All
but one had debut of symptoms before 3 months of age.
The main symptom at presentation was pain be-
haviour/abdominal colic in 13 of 27 children. Seven of these
children had additional symptoms. Four had excessive vom-
iting, one had atopic dermatitis, one had constipation and
one had coughing and wheezing.
Of the seven children, who presented with gastrointesti-
nal symptoms other than pain behaviour, two had excessive
vomiting as the main symptom. Both these children had di-
arrhoea and one had coughing and wheezing. Two other
children presented with constipation as the main symptom.
They also had pain behaviour and vomiting, and one a his-
tory of apnoe. Two of these seven children had visual blood
in the stool. One child presented with diarrhoea.
Six out of 27 presentedwith respiratory symptoms, wheez-
ing and coughing (4) and apnoe (2), but careful questioning
of the parents, as well as clinical examination, revealed that
all these six children had additional symptoms. All had ex-
cessive vomiting, two also had pain behaviour and one child
had atopic dermatitis.
One child presented with atopic dermatitis (Fig. 1).
During the first year of life, 10 children developed atopic
dermatitis. The one child with atopic dermatitis as the pre-
senting symptom was reported during interview. Two other
children were diagnosed with eczema at the first clinical
examination, although their parents had reported pain be-
haviour and respiratory symptoms, respectively, as the only
symptoms. Later during the first year of life, additionally
seven children developed atopic dermatitis, several months
afterthediagnosisofcow’smilkproteinintolerance(CMPI).
IgE-mediated allergy to eggs was found in two children.
The one child with atopic dermatitis as the presenting symp-
tom of CMA also had an allergy to eggs. The second child
developed allergy to eggs and atopic dermatitis at 7 months
of age, 6 months after debut of symptoms of adverse reac-
tions to milk.
Just one child, the one with atopic dermatitis as the pre-
senting symptom, had a positive SPT, as well as elevated IgE
level to cow’s milk proteins.
Eleven children had a positive hemofec test at the first visit
to the hospital. All these children had negative hemofec tests
when tested during the elimination diet, with reappearance
of detectable blood in the stool on challenge.
Sixteen children were exclusively breastfed at symptom
debut, and thus had developed adverse reactions to cow’s
milk proteins in their mother’s milk.
At 1 year of age, 14 of 27 children were tolerant to cow’s
milk, with no reaction to an open challenge test. Nine of the
13 nontolerant children presented with the same symptoms
on challenge as their presenting symptoms, mainly pain be-
haviour. At challenge, four of these children presented ad-
ditional gastrointestinal symptoms, diarrhoea or vomiting.
The four children with change in symptoms, all presented
on challenge with gastrointestinal symptoms, one with di-
arrhoea and the other three with vomiting. Initially, two of
these had respiratory symptoms, and the other two had pain
behaviour.
Nine out of 27 children were premature. They presented
with the same mixture of symptoms as the term children,
and they all had debut of symptoms before 3 months of
age. No statistically significant difference was found be-
tween the occurrences of cow’s milk reactions in the first
year of life among premature infants (9/166 premature in-
fants) compared to the term infants (18 of 389 term in-
fants), with Chi-square value = 0.033, odds ratio (OR) =
0.85.
Six out of 13 nontolerant children at 1 year were
premature.
DISCUSSION
In this study, we have found that adverse reactions to milk
start early in life. All but one in our cohort presented symp-
toms before 3 months of age. Symptoms appeared mainly
in the gastrointestinal and respiratory organs. The majority
of the children had symptoms in more than one organ. We
found just one child with IgE-mediated allergy to cow’s milk.
Half of the children were tolerant to milk at 1 year of age.
The premature children had debut of symptoms at the same
age as the term children, and they also had the same mixture
of symptoms.
In this birth cohort of 555 children, we have found the
frequency of adverse reaction to milk to be 4.9%, which is
in accordance with Moneret-Vautrin, reporting between 2
and 5%, but somewhat more than Host and Martorell, re-
porting 2–3% (1,2,11). We found that 17 of 27 (63%) chil-
dren presented with symptoms during the first month of
life. That most of the children had debut of symptoms be-
fore 3 months of age is in accordance with earlier studies by
Host (1).
In our population, the frequency of atopic dermatitis in
children with adverse reactions to milk was 37% during the
first year of life. We found gastrointestinal symptoms in 66%
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of the children and respiratory symptoms in 37%. This is all
in accordance with other investigators (1,12).
Interestingly, we found just one child with IgE-mediated
CMA that is 3.7% of children with adverse reactions to milk.
This is much less than that reported by Moneret-Vautrin and
Kamelmaz, who reported 14% and 73%, respectively, with
IgE-mediated allergy (2,3).
It may be argued that we might have overlooked some
children with IgE-mediated allergy to cow’s milk. We con-
sider this unlikely, because of the very close follow-up with
personal interviews by phone at 1, 4 and 12 months, and also
written questionnaires at 6 and 12 months. All children with
any symptom, even vague, were invited to an examination,
and no one failed to appear. Therefore, we are quite certain
that in this birth cohort the frequency of IgE-mediated CMA
before 1 year of age is low, that is, 0.2%.
The apparent discrepancy between IgE- and non-IgE-
mediated adverse reactions to milk might be explained by an
over-diagnosing of non-IgE-mediated reactions. We find this
unlikely as the diagnosis was based on convincing results of
the elimination/challenge test, with close follow-up in a hos-
pital setting during the procedure. In cases where the result
of the challenges was inconclusive, we did not consider this
to be an adverse reaction to cow’s milk, even though these
children might possibly have had an early development of
tolerance.
Most of our children were diagnosed between 1 and
4 months of age. In cases of early development of toler-
ance, we might have lost the diagnosis if the interviews or
questionnaires had been postponed until later in the first
year of life, as half of the group were tolerant at 1 year. This
mightexplainthelargenumberofnon-IgE-mediatedadverse
reactions.
Another explanation of the apparent discrepancy between
IgE- and non-IgE-mediated adverse reactions is the rather
surprising finding of respiratory symptoms as the main com-
plaint.Inthesecases,onecouldeasilyoverlookthediagnosis
by examining the child with regard to respiratory infections
or an early debut of asthma.
At1yearofage,allthechildrenhadaplannedopenprovo-
cation at the hospital. Half of the children in our study, 14
of 27, showed no adverse reactions to milk at that age. This
is in accordance with earlier studies by Host and Martorell
(1,11). We find a planned challenge, especially important for
an early diagnosis, based on elimination/challenge tests. In
the lack of objective criteria, one has to keep in mind that
the diagnosis might be wrong, as well as the fact that early
tolerance is usual, and therefore, an early challenge is rea-
sonable.
The child with IgE-mediated CMA was not tolerant at
1y e a ro fa g e .
We find the same frequency and the same symptoms and
age of debut in premature and term children. To our knowl-
edge, there is no report in the literature on these topics. At
1 year, 6 out of 13 nontolerant children were premature.
More term children than premature children had become
tolerant. The difference is not significant; however, the
groups may be too small for evaluation. Theoretically, pre-
mature children may have a tendency to become tolerant
later than term children, due to delayed development of their
immune system.
Weareawareofthefactthatthegoldstandardfordiagnos-
ing food allergy is double-blind, placebo-controlled (DBPC)
challenge (13). In the literature, however, there is support
for open elimination/challenge test below the age of 1 (1).
For practical and clinical reasons, we found it impossible
to do DBPC challenges in the age group of 1–6 months,
when most Norwegian infants are mainly breastfed. It is dif-
ficult, for practical reasons, to carry out the DBPC challenge
through the mother.
Another possibility for an exact diagnosis is to do the
DBPC challenge when the infant is around 1 year of age,
and is having it’s own meals. We intended to do so, to ver-
ify the diagnosis. We did DBPC challenge in eight children,
finding that seven had no adverse reactions to milk at that
time. Thus, the diagnosis was not confirmed in 1-year-old
children. This is not surprising, however, as about 50% of
children are tolerant at 1 year of age (1,4,11).
Consequently, in our opinion, DBPC challenge is not suit-
able for diagnosing adverse reactions to cow’s milk in early
infancy.
In conclusions, in our study, we found that adverse re-
actions to milk are common in infants and occur in 4.9%,
regardless of GA at birth. The symptoms often appear during
the first month or months of life, even in exclusively breast-
fed children.
The diagnosis should be considered in infants with gas-
trointestinal, respiratory and cutaneous symptoms.
If no IgE-mediated allergy is verified, an elimina-
tion/challenge test should be carried out. In our study, non-
IgE-mediated adverse reactions seemed to be much more
common than IgE-mediated reactions in the first year of life.
About half of the children who demonstrated adverse re-
actions to milk in the first months of life did not show any
adverse reactions at 1 year of age. This demonstrates the
importance of performing an open challenge at that time.
Children with prevailing allergies might either maintain
their symptoms or acquire new or additional symptoms.
For practical, economical and social reasons, it is impor-
tant to establish when the age of tolerance occurs in a child
diagnosed with adverse reactions to milk.
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